RAGE supports parathyroid hormone-induced gains in femoral trabecular bone (Q33520403)

27 July 2017

RAGE supports parathyroid hormone-induced gains in femoral trabecular bone (English)

1 reference

27 July 2017

5

Peter P Nawroth

1 reference

27 July 2017

6

Angelika Bierhaus

1 reference

27 July 2017

Binu K Philip

1

1 reference

27 July 2017

Paul J Childress

2

1 reference

27 July 2017

Alexander G Robling

3

1 reference

27 July 2017

Aaron Heller

4

1 reference

27 July 2017

Joseph P Bidwell

7

1 reference

27 July 2017

22 December 2009

1 reference

American Journal of Physiology - Endocrinology and Metabolism

27 July 2017

1 reference

27 July 2017

298

1 reference

27 July 2017

3

1 reference

27 July 2017

E714-25

1 reference

Fat targets for skeletal health

27 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Nmp4/CIZ suppresses parathyroid hormone-induced increases in trabecular bone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Teriparatide: a review of its use in osteoporosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

The dynamic interplay between osteoclasts and the immune system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Is HMGB1 an osteocyte alarmin?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Molecular and cellular mechanisms of the anabolic effect of intermittent PTH

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

RAGE in inflammation: a new therapeutic target?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Regulation of osteoclast function and bone mass by RAGE.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Selective Runx2-II deficiency leads to low-turnover osteopenia in adult mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Mechanisms of sex steroid effects on bone.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Minireview: the OPG/RANKL/RANK system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838526

Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43.

21 June 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00564.2009

Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00564.2009

Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00564.2009

Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00564.2009

New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00564.2009

HMGB1 is a bone-active cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00564.2009

Quantification of age-related changes in the structure model type and trabecular thickness of human tibial cancellous bone

21 January 2018

1 reference

12 December 2020

Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis)

1 reference

12 December 2020

Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study

1 reference

12 December 2020

Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial

1 reference

12 December 2020

Benefit of systemically administered rhIGF-I and rhIGF-I/IGFBP-3 on cancellous bone in ovariectomized rats

1 reference

12 December 2020

Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone

1 reference

12 December 2020

Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss

1 reference

12 December 2020

Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma

1 reference

12 December 2020

Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts

1 reference

12 December 2020

10.1152/AJPENDO.00564.2009

Identifiers

DOI

1 reference

27 July 2017

1 reference

27 July 2017

1 reference